Asymchem acquires former Pfizer small molecule API pilot plant in Sandwich, UK
Establishing Asymchem’s first manufacturing footprint in Europe
Establishing Asymchem’s first manufacturing footprint in Europe
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Pharma Solutions operates 10 research and development and/or production sites globally
The pilot plant is focused on scaling up beverage production and will support applications
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Subscribe To Our Newsletter & Stay Updated